Global Cancer Biopsy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 113
Published Date: 01 Jan 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.
According to our (Global Info Research) latest study, the global Cancer Biopsy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cancer Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cancer Biopsy market size and forecasts, in consumption value ($ Million), 2018-2029
Global Cancer Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Cancer Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Cancer Biopsy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cancer Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cancer Biopsy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics and Hologic, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Cancer Biopsy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tissue Biopsies
Liquid Biopsies
Others
Market segment by Application
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Market segment by players, this report covers
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cancer Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cancer Biopsy, with revenue, gross margin and global market share of Cancer Biopsy from 2018 to 2023.
Chapter 3, the Cancer Biopsy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cancer Biopsy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Cancer Biopsy.
Chapter 13, to describe Cancer Biopsy research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cancer Biopsy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cancer Biopsy by Type
1.3.1 Overview: Global Cancer Biopsy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cancer Biopsy Consumption Value Market Share by Type in 2022
1.3.3 Tissue Biopsies
1.3.4 Liquid Biopsies
1.3.5 Others
1.4 Global Cancer Biopsy Market by Application
1.4.1 Overview: Global Cancer Biopsy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Breast Cancer
1.4.3 Colorectal Cancer
1.4.4 Cervical Cancers
1.4.5 Lung Cancers
1.4.6 Prostate Cancers
1.4.7 Skin Cancers
1.4.8 Blood Cancers
1.4.9 Kidney Cancers
1.4.10 Others
1.5 Global Cancer Biopsy Market Size & Forecast
1.6 Global Cancer Biopsy Market Size and Forecast by Region
1.6.1 Global Cancer Biopsy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cancer Biopsy Market Size by Region, (2018-2029)
1.6.3 North America Cancer Biopsy Market Size and Prospect (2018-2029)
1.6.4 Europe Cancer Biopsy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cancer Biopsy Market Size and Prospect (2018-2029)
1.6.6 South America Cancer Biopsy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cancer Biopsy Market Size and Prospect (2018-2029)
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Cancer Biopsy Product and Solutions
2.1.4 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Illumina, Inc.
2.2.1 Illumina, Inc. Details
2.2.2 Illumina, Inc. Major Business
2.2.3 Illumina, Inc. Cancer Biopsy Product and Solutions
2.2.4 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Illumina, Inc. Recent Developments and Future Plans
2.3 ANGLE Plc
2.3.1 ANGLE Plc Details
2.3.2 ANGLE Plc Major Business
2.3.3 ANGLE Plc Cancer Biopsy Product and Solutions
2.3.4 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ANGLE Plc Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Cancer Biopsy Product and Solutions
2.4.4 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Hologic, Inc.
2.5.1 Hologic, Inc. Details
2.5.2 Hologic, Inc. Major Business
2.5.3 Hologic, Inc. Cancer Biopsy Product and Solutions
2.5.4 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hologic, Inc. Recent Developments and Future Plans
2.6 Biocept, Inc.
2.6.1 Biocept, Inc. Details
2.6.2 Biocept, Inc. Major Business
2.6.3 Biocept, Inc. Cancer Biopsy Product and Solutions
2.6.4 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Biocept, Inc. Recent Developments and Future Plans
2.7 Thermo Fisher Scientific, Inc.
2.7.1 Thermo Fisher Scientific, Inc. Details
2.7.2 Thermo Fisher Scientific, Inc. Major Business
2.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Solutions
2.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Cancer Biopsy Product and Solutions
2.8.4 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Lucence Diagnostics Pte. Ltd.
2.9.1 Lucence Diagnostics Pte. Ltd. Details
2.9.2 Lucence Diagnostics Pte. Ltd. Major Business
2.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Solutions
2.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments and Future Plans
2.10 GRAIL, Inc.
2.10.1 GRAIL, Inc. Details
2.10.2 GRAIL, Inc. Major Business
2.10.3 GRAIL, Inc. Cancer Biopsy Product and Solutions
2.10.4 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GRAIL, Inc. Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Cancer Biopsy Product and Solutions
2.11.4 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 Exact Sciences Corporation
2.12.1 Exact Sciences Corporation Details
2.12.2 Exact Sciences Corporation Major Business
2.12.3 Exact Sciences Corporation Cancer Biopsy Product and Solutions
2.12.4 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Exact Sciences Corporation Recent Developments and Future Plans
2.13 Freenome Holdings, Inc.
2.13.1 Freenome Holdings, Inc. Details
2.13.2 Freenome Holdings, Inc. Major Business
2.13.3 Freenome Holdings, Inc. Cancer Biopsy Product and Solutions
2.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Freenome Holdings, Inc. Recent Developments and Future Plans
2.14 Oncimmune
2.14.1 Oncimmune Details
2.14.2 Oncimmune Major Business
2.14.3 Oncimmune Cancer Biopsy Product and Solutions
2.14.4 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Oncimmune Recent Developments and Future Plans
2.15 Chronix Biomedical, Inc.
2.15.1 Chronix Biomedical, Inc. Details
2.15.2 Chronix Biomedical, Inc. Major Business
2.15.3 Chronix Biomedical, Inc. Cancer Biopsy Product and Solutions
2.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Chronix Biomedical, Inc. Recent Developments and Future Plans
2.16 Personal Genome Diagnostics Inc.
2.16.1 Personal Genome Diagnostics Inc. Details
2.16.2 Personal Genome Diagnostics Inc. Major Business
2.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Product and Solutions
2.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Personal Genome Diagnostics Inc. Recent Developments and Future Plans
3.1 Global Cancer Biopsy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cancer Biopsy by Company Revenue
3.2.2 Top 3 Cancer Biopsy Players Market Share in 2022
3.2.3 Top 6 Cancer Biopsy Players Market Share in 2022
3.3 Cancer Biopsy Market: Overall Company Footprint Analysis
3.3.1 Cancer Biopsy Market: Region Footprint
3.3.2 Cancer Biopsy Market: Company Product Type Footprint
3.3.3 Cancer Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Cancer Biopsy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cancer Biopsy Market Forecast by Type (2024-2029)
5.1 Global Cancer Biopsy Consumption Value Market Share by Application (2018-2023)
5.2 Global Cancer Biopsy Market Forecast by Application (2024-2029)
6.1 North America Cancer Biopsy Consumption Value by Type (2018-2029)
6.2 North America Cancer Biopsy Consumption Value by Application (2018-2029)
6.3 North America Cancer Biopsy Market Size by Country
6.3.1 North America Cancer Biopsy Consumption Value by Country (2018-2029)
6.3.2 United States Cancer Biopsy Market Size and Forecast (2018-2029)
6.3.3 Canada Cancer Biopsy Market Size and Forecast (2018-2029)
6.3.4 Mexico Cancer Biopsy Market Size and Forecast (2018-2029)
7.1 Europe Cancer Biopsy Consumption Value by Type (2018-2029)
7.2 Europe Cancer Biopsy Consumption Value by Application (2018-2029)
7.3 Europe Cancer Biopsy Market Size by Country
7.3.1 Europe Cancer Biopsy Consumption Value by Country (2018-2029)
7.3.2 Germany Cancer Biopsy Market Size and Forecast (2018-2029)
7.3.3 France Cancer Biopsy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cancer Biopsy Market Size and Forecast (2018-2029)
7.3.5 Russia Cancer Biopsy Market Size and Forecast (2018-2029)
7.3.6 Italy Cancer Biopsy Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Cancer Biopsy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cancer Biopsy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cancer Biopsy Market Size by Region
8.3.1 Asia-Pacific Cancer Biopsy Consumption Value by Region (2018-2029)
8.3.2 China Cancer Biopsy Market Size and Forecast (2018-2029)
8.3.3 Japan Cancer Biopsy Market Size and Forecast (2018-2029)
8.3.4 South Korea Cancer Biopsy Market Size and Forecast (2018-2029)
8.3.5 India Cancer Biopsy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cancer Biopsy Market Size and Forecast (2018-2029)
8.3.7 Australia Cancer Biopsy Market Size and Forecast (2018-2029)
9.1 South America Cancer Biopsy Consumption Value by Type (2018-2029)
9.2 South America Cancer Biopsy Consumption Value by Application (2018-2029)
9.3 South America Cancer Biopsy Market Size by Country
9.3.1 South America Cancer Biopsy Consumption Value by Country (2018-2029)
9.3.2 Brazil Cancer Biopsy Market Size and Forecast (2018-2029)
9.3.3 Argentina Cancer Biopsy Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Cancer Biopsy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cancer Biopsy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cancer Biopsy Market Size by Country
10.3.1 Middle East & Africa Cancer Biopsy Consumption Value by Country (2018-2029)
10.3.2 Turkey Cancer Biopsy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cancer Biopsy Market Size and Forecast (2018-2029)
10.3.4 UAE Cancer Biopsy Market Size and Forecast (2018-2029)
11.1 Cancer Biopsy Market Drivers
11.2 Cancer Biopsy Market Restraints
11.3 Cancer Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12.1 Cancer Biopsy Industry Chain
12.2 Cancer Biopsy Upstream Analysis
12.3 Cancer Biopsy Midstream Analysis
12.4 Cancer Biopsy Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cancer Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cancer Biopsy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cancer Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cancer Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Qiagen N.V. Company Information, Head Office, and Major Competitors
Table 6. Qiagen N.V. Major Business
Table 7. Qiagen N.V. Cancer Biopsy Product and Solutions
Table 8. Qiagen N.V. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Qiagen N.V. Recent Developments and Future Plans
Table 10. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 11. Illumina, Inc. Major Business
Table 12. Illumina, Inc. Cancer Biopsy Product and Solutions
Table 13. Illumina, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Illumina, Inc. Recent Developments and Future Plans
Table 15. ANGLE Plc Company Information, Head Office, and Major Competitors
Table 16. ANGLE Plc Major Business
Table 17. ANGLE Plc Cancer Biopsy Product and Solutions
Table 18. ANGLE Plc Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. ANGLE Plc Recent Developments and Future Plans
Table 20. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 21. Myriad Genetics Major Business
Table 22. Myriad Genetics Cancer Biopsy Product and Solutions
Table 23. Myriad Genetics Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Myriad Genetics Recent Developments and Future Plans
Table 25. Hologic, Inc. Company Information, Head Office, and Major Competitors
Table 26. Hologic, Inc. Major Business
Table 27. Hologic, Inc. Cancer Biopsy Product and Solutions
Table 28. Hologic, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hologic, Inc. Recent Developments and Future Plans
Table 30. Biocept, Inc. Company Information, Head Office, and Major Competitors
Table 31. Biocept, Inc. Major Business
Table 32. Biocept, Inc. Cancer Biopsy Product and Solutions
Table 33. Biocept, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Biocept, Inc. Recent Developments and Future Plans
Table 35. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 36. Thermo Fisher Scientific, Inc. Major Business
Table 37. Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Solutions
Table 38. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 40. Danaher Company Information, Head Office, and Major Competitors
Table 41. Danaher Major Business
Table 42. Danaher Cancer Biopsy Product and Solutions
Table 43. Danaher Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Danaher Recent Developments and Future Plans
Table 45. Lucence Diagnostics Pte. Ltd. Company Information, Head Office, and Major Competitors
Table 46. Lucence Diagnostics Pte. Ltd. Major Business
Table 47. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Solutions
Table 48. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Lucence Diagnostics Pte. Ltd. Recent Developments and Future Plans
Table 50. GRAIL, Inc. Company Information, Head Office, and Major Competitors
Table 51. GRAIL, Inc. Major Business
Table 52. GRAIL, Inc. Cancer Biopsy Product and Solutions
Table 53. GRAIL, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. GRAIL, Inc. Recent Developments and Future Plans
Table 55. Guardant Health Company Information, Head Office, and Major Competitors
Table 56. Guardant Health Major Business
Table 57. Guardant Health Cancer Biopsy Product and Solutions
Table 58. Guardant Health Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Guardant Health Recent Developments and Future Plans
Table 60. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 61. Exact Sciences Corporation Major Business
Table 62. Exact Sciences Corporation Cancer Biopsy Product and Solutions
Table 63. Exact Sciences Corporation Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Exact Sciences Corporation Recent Developments and Future Plans
Table 65. Freenome Holdings, Inc. Company Information, Head Office, and Major Competitors
Table 66. Freenome Holdings, Inc. Major Business
Table 67. Freenome Holdings, Inc. Cancer Biopsy Product and Solutions
Table 68. Freenome Holdings, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Freenome Holdings, Inc. Recent Developments and Future Plans
Table 70. Oncimmune Company Information, Head Office, and Major Competitors
Table 71. Oncimmune Major Business
Table 72. Oncimmune Cancer Biopsy Product and Solutions
Table 73. Oncimmune Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Oncimmune Recent Developments and Future Plans
Table 75. Chronix Biomedical, Inc. Company Information, Head Office, and Major Competitors
Table 76. Chronix Biomedical, Inc. Major Business
Table 77. Chronix Biomedical, Inc. Cancer Biopsy Product and Solutions
Table 78. Chronix Biomedical, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Chronix Biomedical, Inc. Recent Developments and Future Plans
Table 80. Personal Genome Diagnostics Inc. Company Information, Head Office, and Major Competitors
Table 81. Personal Genome Diagnostics Inc. Major Business
Table 82. Personal Genome Diagnostics Inc. Cancer Biopsy Product and Solutions
Table 83. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Personal Genome Diagnostics Inc. Recent Developments and Future Plans
Table 85. Global Cancer Biopsy Revenue (USD Million) by Players (2018-2023)
Table 86. Global Cancer Biopsy Revenue Share by Players (2018-2023)
Table 87. Breakdown of Cancer Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Cancer Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Cancer Biopsy Players
Table 90. Cancer Biopsy Market: Company Product Type Footprint
Table 91. Cancer Biopsy Market: Company Product Application Footprint
Table 92. Cancer Biopsy New Market Entrants and Barriers to Market Entry
Table 93. Cancer Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Cancer Biopsy Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Cancer Biopsy Consumption Value Share by Type (2018-2023)
Table 96. Global Cancer Biopsy Consumption Value Forecast by Type (2024-2029)
Table 97. Global Cancer Biopsy Consumption Value by Application (2018-2023)
Table 98. Global Cancer Biopsy Consumption Value Forecast by Application (2024-2029)
Table 99. North America Cancer Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Cancer Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Cancer Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Cancer Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Cancer Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Cancer Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Cancer Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Cancer Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Cancer Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Cancer Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Cancer Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Cancer Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Cancer Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Cancer Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Cancer Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Cancer Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Cancer Biopsy Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Cancer Biopsy Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Cancer Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Cancer Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Cancer Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Cancer Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Cancer Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Cancer Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Cancer Biopsy Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Cancer Biopsy Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Cancer Biopsy Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Cancer Biopsy Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Cancer Biopsy Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Cancer Biopsy Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Cancer Biopsy Raw Material
Table 130. Key Suppliers of Cancer Biopsy Raw Materials
List of Figures
Figure 1. Cancer Biopsy Picture
Figure 2. Global Cancer Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cancer Biopsy Consumption Value Market Share by Type in 2022
Figure 4. Tissue Biopsies
Figure 5. Liquid Biopsies
Figure 6. Others
Figure 7. Global Cancer Biopsy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Cancer Biopsy Consumption Value Market Share by Application in 2022
Figure 9. Breast Cancer Picture
Figure 10. Colorectal Cancer Picture
Figure 11. Cervical Cancers Picture
Figure 12. Lung Cancers Picture
Figure 13. Prostate Cancers Picture
Figure 14. Skin Cancers Picture
Figure 15. Blood Cancers Picture
Figure 16. Kidney Cancers Picture
Figure 17. Others Picture
Figure 18. Global Cancer Biopsy Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 19. Global Cancer Biopsy Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 20. Global Market Cancer Biopsy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 21. Global Cancer Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 22. Global Cancer Biopsy Consumption Value Market Share by Region in 2022
Figure 23. North America Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East and Africa Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Cancer Biopsy Revenue Share by Players in 2022
Figure 29. Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 30. Global Top 3 Players Cancer Biopsy Market Share in 2022
Figure 31. Global Top 6 Players Cancer Biopsy Market Share in 2022
Figure 32. Global Cancer Biopsy Consumption Value Share by Type (2018-2023)
Figure 33. Global Cancer Biopsy Market Share Forecast by Type (2024-2029)
Figure 34. Global Cancer Biopsy Consumption Value Share by Application (2018-2023)
Figure 35. Global Cancer Biopsy Market Share Forecast by Application (2024-2029)
Figure 36. North America Cancer Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 37. North America Cancer Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 38. North America Cancer Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 40. Canada Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 41. Mexico Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 42. Europe Cancer Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 43. Europe Cancer Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 44. Europe Cancer Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 46. France Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 47. United Kingdom Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 48. Russia Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 49. Italy Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Cancer Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Cancer Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Cancer Biopsy Consumption Value Market Share by Region (2018-2029)
Figure 53. China Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 54. Japan Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 55. South Korea Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 56. India Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 57. Southeast Asia Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 58. Australia Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 59. South America Cancer Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 60. South America Cancer Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 61. South America Cancer Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 63. Argentina Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 64. Middle East and Africa Cancer Biopsy Consumption Value Market Share by Type (2018-2029)
Figure 65. Middle East and Africa Cancer Biopsy Consumption Value Market Share by Application (2018-2029)
Figure 66. Middle East and Africa Cancer Biopsy Consumption Value Market Share by Country (2018-2029)
Figure 67. Turkey Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 68. Saudi Arabia Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 69. UAE Cancer Biopsy Consumption Value (2018-2029) & (USD Million)
Figure 70. Cancer Biopsy Market Drivers
Figure 71. Cancer Biopsy Market Restraints
Figure 72. Cancer Biopsy Market Trends
Figure 73. Porters Five Forces Analysis
Figure 74. Manufacturing Cost Structure Analysis of Cancer Biopsy in 2022
Figure 75. Manufacturing Process Analysis of Cancer Biopsy
Figure 76. Cancer Biopsy Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Qiagen N.V. Illumina, Inc. ANGLE Plc Myriad Genetics Hologic, Inc. Biocept, Inc. Thermo Fisher Scientific, Inc. Danaher Lucence Diagnostics Pte. Ltd. GRAIL, Inc. Guardant Health Exact Sciences Corporation Freenome Holdings, Inc. Oncimmune Chronix Biomedical, Inc. Personal Genome Diagnostics Inc.
Related Reports
28 Jan 2021
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
